Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summary

S. Rugo, Hope; Brufsky, Adam; Liu, Xianchen; Li, Benjamin; McRoy, Lynn; Chen, Connie; Layman, Rachel M; Cristofanilli, Massimo; Torres, Mylin A.; Curigliano, Giuseppe; Finn, Richard S.; DeMichele, Angela

doi:10.25402/FON.22242118.v2

PZBC023 P-realityX video M6 March 10 final.mp4 (14.86 MB)

Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summary

presentation

posted on 2023-03-13, 13:52 authored by Hope S. Rugo, Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Massimo Cristofanilli, Mylin A. Torres, Giuseppe Curigliano, Richard S. Finn, Angela DeMichele

Video to go with:

Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summary

History

Usage metrics

Keywords

real-world plain language summary palbociclib overall survival metastatic breast cancer lay summary HR+/HER2–aromatase inhibitor

Licence

CC BY-NC-ND 4.0

Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summary

History

Usage metrics

Categories

Keywords

Licence

Exports